Medici Capital LLC boosted its holdings in shares of EMX Royalty Co. (NYSEAMERICAN:EMX - Free Report) by 46.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,000,850 shares of the company's stock after acquiring an additional 633,850 shares during the quarter. EMX Royalty accounts for about 5.0% of Medici Capital LLC's investment portfolio, making the stock its 5th largest holding. Medici Capital LLC owned 1.84% of EMX Royalty worth $4,088,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of EMX. Sprott Inc. raised its holdings in shares of EMX Royalty by 31.4% during the fourth quarter. Sprott Inc. now owns 3,014,481 shares of the company's stock worth $5,219,000 after acquiring an additional 720,458 shares in the last quarter. Privium Fund Management B.V. acquired a new position in EMX Royalty in the 4th quarter worth about $375,000. Eagle Global Advisors LLC purchased a new stake in shares of EMX Royalty during the 4th quarter worth about $201,000. Virtu Financial LLC lifted its holdings in shares of EMX Royalty by 161.0% during the 4th quarter. Virtu Financial LLC now owns 90,500 shares of the company's stock valued at $157,000 after buying an additional 55,827 shares during the last quarter. Finally, BNP Paribas Financial Markets grew its stake in shares of EMX Royalty by 12.6% in the 4th quarter. BNP Paribas Financial Markets now owns 87,700 shares of the company's stock valued at $152,000 after buying an additional 9,800 shares in the last quarter. Hedge funds and other institutional investors own 21.54% of the company's stock.
EMX Royalty Stock Up 0.4%
EMX stock opened at $2.48 on Tuesday. The firm has a market cap of $269.82 million, a PE ratio of -62.00 and a beta of 0.81. EMX Royalty Co. has a 1 year low of $1.59 and a 1 year high of $2.50. The company has a fifty day simple moving average of $2.24 and a 200 day simple moving average of $1.93. The company has a current ratio of 13.15, a quick ratio of 13.15 and a debt-to-equity ratio of 0.30.
Analyst Ratings Changes
Separately, HC Wainwright cut their price objective on shares of EMX Royalty from $7.00 to $5.00 and set a "buy" rating on the stock in a research report on Friday, March 14th.
View Our Latest Report on EMX
About EMX Royalty
(
Free Report)
EMX Royalty Corporation, together with its subsidiaries, explores for and generates royalties from metals and minerals properties. It explores gold, silver, platinum, palladium, copper, lead, zinc, manganese, nickel, cobalt, molybdenum, and iron deposits, as well as battery, precious, and base metals.
See Also
Want to see what other hedge funds are holding EMX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for EMX Royalty Co. (NYSEAMERICAN:EMX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EMX Royalty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EMX Royalty wasn't on the list.
While EMX Royalty currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.